ArticleOne health (Amsterdam, Netherlands)2021
Extended spectrum beta-lactamase-producing
Article in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07106944 (Extended Tricyle Project Indonesia for Extended-spectrum Beta-lactamase Positive Klebsiella Pneumoniae and Escherichia Coli), which is not on this map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Extended Tricyle Project Indonesia for Extended-spectrum Beta-lactamase Positive Klebsiella Pneumoniae and Escherichia Coli
Who cites it
19 citing papers in PubMed, 44 citations in OpenAlex.
- Antimicrobial Resistance and One Health: Lessons on One Health Governance and Implementation from the Fleming Fund.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Frequency and characteristics of extended-spectrum beta-lactamase-producing Escherichia coli in wastewater in Dakar, Senegal.BMC research notes · 2026Article
- Antimicrobial Susceptibility Profiles of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated From Intensively Reared and Free-Range Chickens in Selected Districts of Zambia.Veterinary medicine and science · 2026Article
- Strengthening antimicrobial resistance governance in Europe: a coordinated one health approach.The Lancet regional health. Europe · 2026Review
- High Prevalence and Genomic Characterization of Extended-SpectrumChina CDC weekly · 2025Article
- Evaluation of a modified IDEXX method for antimicrobial resistance monitoring of extended Beta-lactamases-producingOne health (Amsterdam, Netherlands) · 2025Article
- Assessment of the environmental transmission dynamics ofOpen veterinary journal · 2025Article
- Sources and Transmission Routes of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025Article
- Article
- Prevalence, Antimicrobial Susceptibility, and Resistance Genes of Extended-Spectrum β-Lactamase-ProducingMicroorganisms · 2024Article
- Distribution of extended-spectrum β-lactamase producingVeterinary world · 2024Article
- Occurrence, antibiotic resistance profiles and associated risk factors of Klebsiella pneumoniae in poultry farms in selected districts of Somalia Reginal State, Ethiopia.BMC microbiology · 2024Article
- Metagenome and Resistome Analysis of Beta-Lactam-Resistant Bacteria Isolated from River Waters in Surabaya, Indonesia.Microorganisms · 2024Article
- Prevalence of Extended-Spectrum Beta-Lactamase (ESBL)-ProducingInternational journal of microbiology · 2024Article
- Extended-spectrum beta-lactamase-producing Enterobacterales in human health: Experience from the tricycle project, Ghana.PloS one · 2024Article
- Response to antimicrobial resistance in South-East Asia Region.The Lancet regional health. Southeast Asia · 2023Review
- Lessons from a global antimicrobial resistance surveillance network.Bulletin of the World Health Organization · 2023Article
- Extended spectrum beta lactamase (ESBL)-producingAIMS microbiology · 2023Article
- Prevalence and characterization of ESBL-producingFrontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 6 institutions in 4 countries.
Funding
Abstract
The World Health Organization (WHO) has been implementing antimicrobial surveillance with a "One Health" approach, known as the Global Surveillance ESBL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.